Healthy sleep is required to ensure the body’s homeostatic stability, the consistency of immunological reactions, and optimum functioning of the internal organs, the nervous system, and cognitive functions. Patterns of changes to the circadian rhythms have been studied in many diseases, though infection with SARS-CoV-2 is a new reality and the basic mechanisms of functioning of the body in this pathology require deeper investigation. Despite the difficulty of analytical investigations in pandemic conditions, experience of the diagnosis of COVID-19 has now been acquired and treatment algorithms have been developed for different clinical situations; vaccines have been developed. Least studied are questions of the long-term sequelae of COVID-19. At the same time, there are good grounds for suggesting that patients need long-term rehabilitation in the post-covid period of SARS-CoV-2, for reasons including damage to the nervous system. Analysis of publications – from descriptions of clinical cases to literature reviews – allows empirical experience to be accumulated, providing the opportunity for future identification of prognostic markers for the disease for effective prevention of long-term sequelae. The results of current prospective studies draw attention to the occurrence of dyssomnia and obstructive sleep apnea not only as a common consequence of coronavirus infection, but also as a factor significantly worsening the prognosis in the acute period of illness. It has repeatedly been shown that sleep deprivation has adverse influences on the body’s resistance, including to SARS-CoV-2, and requires correction to improve prognoses in the acute and long-term periods of illness in COVID-19 patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
J. M. Krueger, M. G. Frank, J. P. Wisor, and S. Roy, “Sleep function: toward elucidating an enigma,” Sleep Med. Rev., 28, 46–54 (2016), https://doi.org/10.1016/j.smrv.2015.08.005.
National Sleep Foundation (NSF), Sleep in America Poll: Summary of Findings, NSF, Washington, DC (2009), https://doi.org/10.1016/j.sleh.2015.04.007.
A. G. Silva, D. M. Miranda, A. P. Diaz, et al., “Mental health: why it still matters in the midst of a pandemic,” Braz. J. Psychiatry, 42, No. 3, 229–231 (2020), https://doi.org/10.1590/1516-4446-2020-0009.
S. K. Brooks, R. K. Webster, L. E. Smith, et al., “The psychological impact of quarantine and how to reduce it: rapid review of the evidence,” Lancet, 395, No. 10227, 912–920 (2020), https://doi.org/10.1016/S0140-6736(20)30460-8.
T. Akıncı and H. M. Basar, “Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19,” Sleep Med., 80, 167–170 (2021), https://doi.org/10.1016/j.sleep.2021.01.034.
Ch. Huang, L. Huang, Y. Wang, et al., “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,” Lancet, 397, 220–232 (2021), https://doi.org/10.1016/S0140-6736(20)30183-5.
M. H. Lam, Y. K. Wing, M. W. Yu, et al., “Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up,” Arch. Intern. Med., 169, 2142–2147 (2009), https://doi.org/10.1001/archinternmed.2009.384.
H. Jahrami, A. S. BaHammam, N. L. Bragazzi, et al., “Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis,” J. Clin. Sleep Med., 17, No. 2, 299–313 (2021),https://doi.org/10.5664/jcsm.8930.
E. Garrigues, P. Janvier, Y. Kherabi, et al., “Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19,” J. Infect., 81, No. 6, 4–6 (2020), https://doi.org/10.1016/j.jinf.2020.08.029.
S. Mandal, J. Barnett, S. E. Brill, et al., “Long-COVID: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19,” Thorax, 76, 396–398 (2021), https://doi.org/10.1136/thoraxjnl-2020-215818.
M. Taquet, S. Luciano, J. R. Geddes, and P. J. Harrison, “Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62,354 COVID-19 cases in the USA,” The Lancet Psychiatry, 8, No. 2 (2021), https://doi.org/10.1016/S2215-0366(20)30462-4.
J. Ludvigsson, “Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19,” Acta Paediatr., 110, No. 3, 914–921 (2020), https://doi.org/10.1111/apa.15673.
J. A. Vitale, P. Perazzo, M. Silingardi, et al., “Is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination,” Chronobiol. Int., 37, No. 7, 1110–1114 (2020), https://doi.org/10.1080/07420528.2020.1775241.
V. Tsara, A. Amfilochiou, M. J. Papagrigorakis, et al., “Definition and classification of sleep related breathing disorders in adults,” Hippokratia, 13, No. 3, 187–191 (2009).
A. V. Benjafield, N. T. Ayas, P. R. Eastwood, et al., “Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis,” Lancet Respir. Med., 7, No. 8, 687–698 (2019), https://doi.org/10.1016/S2213-2600(19)30198-5.
M. A. Miller and F. P. Cappuccio, “A systematic review of COVID-19 and obstructive sleep apnoea,” Sleep Med. Rev., 55, 101382 (2021), https://doi.org/10.1016/j.smrv.2020.101382.
B. Cariou, S. Hadjadj, M. Wargny, et al., “Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study,” Diabetologia, 63, No. 8, 1500–1515 (2020), https://doi.org/10.1007/s00125-020-05180-x.
R. M. Abrams, “Sleep deprivation,” Obst. Gynecol. Clin. North Am., 42, No. 3, 493–506 (2015), https://doi.org/10.1016/j.ogc.2015.05.013.
O. V. Reeth, L. Weibel, K. Spiegel, et al., “Interactions between stress and sleep: from basic research to clinical situations.,” Sleep Med. Rev., 2, 201–219 (2000), https://doi.org/10.1053/smrv.1999.0097.
C. E. Gamaldo, A. K. Shaikh, and J. C. McArthur, “The sleep-immunity relationship,” Neurol. Clin., 30, 1313e43 (2012), https://doi.org/10.1016/j.ncl.2012.08.007.
H. Xiao, Y. Zhang, D. Kong, et al., “Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China,” Med. Sci. Monit., 26, 921e3 (2020), https://doi.org/10.12659/MSM.923921.
T. Akerstedt, “Psychosocial stress and impaired sleep,” Scand. J. Work Environ. Health, 32, 493e501 (2006).
M. Irwin, C. Clark, B. Kennedy, et al., “Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects,” Brain Behav. Immun., 17, 365e72 (2003), https://doi.org/10.1016/s0889-1591(03)00031-x.
L. Redwine, R. L. Hauger, J. C. Gillin, and M. Irwin, “Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans,” J. Clin. Endocrinol. Metab., 85, No. 10, 3597–3603 (2000), https://doi.org/10.1210/jcem.85.10.6871.
A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, et al., “Circadian interleukin-6 secretion and quantity and depth of sleep,” J. Clin. Endocrinol. Metab., 84, No. 8, 2603–2607 (1999), https://doi.org/10.1210/jcem.84.8.5894.
J. Savard, L. Laroche, S. Simard, et al., “Chronic insomnia and immune functioning,” Psychosom. Med., 65, No. 2, 211–221 (2003), https://doi.org/10.1097/01.psy.0000033126.22740.f3.
J. Born, T. Lange, K. Hansen, et al., “Effects of sleep and circadian rhythm on human circulating immune cells,” J. Immunol., 158, No. 9, 4454–4464 (1997).
M. Irwin, J. McClintick, C. Costlow, et al., “Partial night sleep deprivation reduces natural killer and cellular immune responses in humans,” FASEB J., 10, No. 5, 643–653 (1996), https://doi.org/10.1096/fasebj.10.5.8621064.
M. Irwin, J. Thompson, C. Miller, et al., “Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications,” J. Clin. Endocrinol. Metab., 84, No. 6, 1979– 1985 (1999), https://doi.org/10.1210/jcem.84.6.5788.
S. Dimitrov, T. Lange, S. Tieken, et al., “Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans,” Brain Behav. Immun., 18, No. 4, 341–348 (2004), https://doi.org/10.1016/j.bbi.2003.08.004.
T. Lange, S. Dimitrov, H. L. Fehm, and J. Born, “Sleep-like concentrations of growth hormone and cortisol modulate type 1 and type 2 in-vitro cytokine production in human T cells,” Int. Immunopharmacol., 6, No. 2, 216–225 (2006), Epub Aug. 31, 2005, https://doi.org/10.1016/j.intimp.2005.08.006.
T. Lange, S. Dimitrov, H. L. Fehm, et al., “Shift of monocyte function toward cellular immunity during sleep,” Arch. Intern. Med., 166, No. 16, 1695–1700 (2006), https://doi.org/10.1001/archinte.166.16.1695.
L. Redwine, J. Dang, M. Hall, and M. Irwin, “Disordered sleep, nocturnal cytokines, and immunity in alcoholics,” Psychosom. Med., 65, No. 1, 75–85 (2003), https://doi.org/10.1097/01.psy.0000038943.33335.d2.
E. A. Said, M. A. Al-Abri, I. Al-Saidi, et al., “Sleep deprivation alters neutrophil functions and levels of Th1-related chemokines and CD4+ T cells in the blood,” Sleep Breath., 23, No. 4, 1331–1339 (2019), https://doi.org/10.1007/s11325-019-01851-1.
K. Spiegel, J. F. Sheridan, and E. Van Cauter, “Effect of sleep deprivation on response to immunization,” JAMA, 288, No. 12, 1471– 1472 (2002), https://doi.org/10.1001/jama.288.12.1471-a.
E. Altena, Ch. Baglioni, C. A. Espie, et al., “Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy,” J. Sleep Res., 29, No. 4, e13052 (2020), https://doi.org/10.1111/jsr.13052EDN:AUGXYM.
A. Qaseem, D. Kansagara, M. A. Forciea, et al., “Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians,” Ann. Intern. Med., 165, No. 2, 125–133 (2016), https://doi.org/10.7326/M15-2175.
D. Riemann, C. Baglioni, C. Bassetti, et al., “European guideline for the diagnosis and treatment of insomnia,” J. Sleep Res., 26, No. 6, 675–700 (2017), Epub Sept. 5, 2017, https://doi.org/10.1111/jsr.12594.
S. J. Wilson, D. J. Nutt, C. Alford, et al., “British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders,” J. Psychopharmacol., 24, No. 11, 1577–1601 (2010), https://doi.org/10.1177/0269881110379307.
D. Riemann and M. L. Perlis, “The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies,” Sleep Med. Rev., 13, 205–214 (2009), https://doi.org/10.1016/j.smrv.2008.06.001.
J. He, L. Yang, J. Pang, et al., “Efficacy of simplified-cognitive behavioral therapy for insomnia(S-CBTI) among female COVID-19 patients with insomnia symptom in Wuhan mobile cabin hospital,” Sleep Breath., 25, 1–7 (2021), https://doi.org/10.1007/s11325-021-02350-y.
K. Liu, Y. Chen, D. Wu, et al., “Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19,” Complement Ther. Clin. Pract., 39, 101132 (2020), https://doi.org/10.1016/j.ctcp.2020.101132.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 121, No. 12, Iss. 1, pp. 119–122, December, 2021.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ahmet’yanov, M.A., Reikhert, L.I., Kicherova, O.A. et al. Sleep Disorders in Patients after COVID-19. Neurosci Behav Physi 52, 645–648 (2022). https://doi.org/10.1007/s11055-022-01290-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-022-01290-8